Search Results 781-790 of 17849 for corticosteroid

1. A Study to Evaluate Pemetrexed and Pembrolizumab to Treat Recurrent and/or Metastatic Salivary Gland Malignancies - Mayo Clinic

   ... corticosteroids or immunosuppressive drugs ... Replacement therapy (e.g., thyroxine, insulin, or physiologic corticosteroid replacement therapy for adrenal or ...

2. Pembrolizumab Alone or With Idelalisib or Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Non-Hodgkin Lymphomas - Mayo Clinic

   Prior oral corticosteroid therapy for an indication other than CLL will not be considered "prior treatment." Previous use of corticosteroids in the ...

3. Kidney Biopsy Clinical Trials - Mayo Clinic Research

   ... corticosteroids. Using C3d Staining to Identify Complement-mediated Hemolytic Uremic Syndrome in Kidney Biopsies Rochester, MN. The aim of this project is to ...

4. COPD Takes the Breath Away; Treatment Can Prevent Worsening - Mayo Clinic News Network

   Inhaled corticosteroids to reduce airway inflammation and prevent sudden exacerbations. Antibiotics to fight respiratory infections and help prevent flare ...

5. Pre-op Pembro + Radiation Therapy in Breast Cancer (P-RAD) - Mayo Clinic

   ... corticosteroids is exclusionary, except the following in the absence of active autoimmune disease: - As premedication for chemotherapy - For the prevention ...

6. Publications - Lioudmila V. Karnatovskaia, M.D. - Mayo Clinic

   The influence of prehospital systemic corticosteroid use on development of acute respiratory distress syndrome and hospital outcomes. Crit Care Med. 2013 ...

7. Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma - Mayo Clinic

   ... corticosteroid therapy (=< 3 weeks of total planned exposure) must still ... corticosteroids or chronic physiologic replacement doses of corticosteroids are ...

8. Publications - Chris R. Carpenter, M.D. - Mayo Clinic

   Corticosteroids for patients with vestibular neuritis: An evidence synthesis for guidelines for reasonable and appropriate care in the emergency department.

9. A 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of QAW039 When Added to Standard-of-care Asthma Therapy in Patients With Uncontrolled Asthma - Mayo Clinic

   Treated with medium dose inhaled corticosteroid (ICS), or high dose ICS, or low dose ICS plus long- acting beta agonist (LABA), or low dose ICS plus ...

10. The purpose of this study is to evaluate itacitinib or placebo in combination with corticosteroids as first-line treatment of participants with Grade II to IV ...